Prevention and treatment of cytomegalovirus disease in solid organ transplant recipients: the clinical and economic impact of evolving strategies. Introduction.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Volumn 60, Issue 23 Suppl 8, 2003, Pages

  Pescovitz, Mark D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ANTIBIOTIC PROPHYLAXIS; CYTOMEGALIC INCLUSION BODY DISEASE; EDITORIAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; VIROLOGY;

ANTIBIOTIC PROPHYLAXIS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNOSUPPRESSION; OPPORTUNISTIC INFECTIONS; ORGAN TRANSPLANTATION;

MLCS; MLOWN;

EID: 1542750507     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.suppl_8.s3     Document Type: Editorial

References (0)